EDGAR Filing Documents for 0001628280-17-006747

Form CORRESP - Correspondence:

SEC Accession No. 0001628280-17-006747

Filing Date

2017-06-27

Accepted

2017-06-27 14:09:25

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	15387
2		filename2.pdf	CORRESP	217812
	Complete submission text file	0001628280-17-006747.txt		316541

Mailing Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170

Business Address 420 LEXINGTON AVENUE SUITE 2525 NEW YORK NY 10170 646-396-4087

Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0331
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations